What is she best known for?
The fields of study she is best known for:
- Gene
- Enzyme
- Internal medicine
Her main research concerns Cotransporter, Biochemistry, Endocrinology, Internal medicine and Bicarbonate.
Her Cotransporter study combines topics in areas such as Epithelial polarity, Proximal renal tubular acidosis, DIDS and Intracellular pH.
Her research in Biochemistry intersects with topics in Computational biology and Cell biology.
Her work on Lipid profile, Coronary artery disease and Salivary gland as part of general Internal medicine study is frequently linked to Acinar cell, therefore connecting diverse disciplines of science.
Her work deals with themes such as Ussing chamber, Carbonic anhydrase II and Density functional theory, which intersect with Bicarbonate.
Ira Kurtz has included themes like Molecular biology, Retina, Cornea, Ciliary body and Bicarbonate transporter protein in her SLC4A4 study.
Her most cited work include:
- Toxic Alcohol Ingestions: Clinical Features, Diagnosis, and Management (253 citations)
- Molecular Cloning, Chromosomal Localization, Tissue Distribution, and Functional Expression of the Human Pancreatic Sodium Bicarbonate Cotransporter (244 citations)
- Metabolic Acidosis of CKD: Diagnosis, Clinical Characteristics, and Treatment (222 citations)
What are the main themes of her work throughout her whole career to date?
Ira Kurtz focuses on Biochemistry, Internal medicine, Endocrinology, Cotransporter and Biophysics.
Her study looks at the relationship between Biochemistry and fields such as Bicarbonate, as well as how they intersect with chemical problems.
Her Metabolic acidosis, Acidosis and Hyponatremia study in the realm of Internal medicine connects with subjects such as Body water.
Her Endocrinology study focuses on Kidney in particular.
She interconnects Molecular biology, Epithelial polarity, Bicarbonate transporter protein and Ion transporter in the investigation of issues within Cotransporter.
Her Bicarbonate transport research is multidisciplinary, incorporating elements of Ameloblast and Cell biology.
She most often published in these fields:
- Biochemistry (29.19%)
- Internal medicine (22.01%)
- Endocrinology (18.18%)
What were the highlights of her more recent work (between 2017-2021)?
- Cell biology (10.05%)
- Thrombotic microangiopathy (3.83%)
- Transporter (8.61%)
In recent papers she was focusing on the following fields of study:
Her primary areas of investigation include Cell biology, Thrombotic microangiopathy, Transporter, Biophysics and Internal medicine.
Her Cell biology research incorporates elements of Cell, Transcriptome and Posterior polymorphous corneal dystrophy.
Her Transporter study combines topics from a wide range of disciplines, such as Combinatorial chemistry, Transport protein and Mutagenesis.
Her studies in Biophysics integrate themes in fields like Nanofiltration, SLC4A4, Sodium-Bicarbonate Symporters, Symporter and Blood chemistry.
Her Internal medicine research incorporates themes from Endocrinology and Metabolic syndrome.
Her study in the fields of Triglyceride, Hyperlipidemia and Hypertriglyceridemia under the domain of Endocrinology overlaps with other disciplines such as Hyperviscosity and Ion selective electrode.
Between 2017 and 2021, her most popular works were:
- CryoEM structure of the human SLC4A4 sodium-coupled acid-base transporter NBCe1 (38 citations)
- Impact of Individual Traits, Saturated Fat, and Protein Source on the Gut Microbiome. (32 citations)
- Nephrotoxicity induced by intravitreal vascular endothelial growth factor inhibitors: emerging evidence (18 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
Ira Kurtz spends much of her time researching Bevacizumab, Thrombotic microangiopathy, Aflibercept, Renal function and Diabetic retinopathy.
Her study on Thrombotic microangiopathy is intertwined with other disciplines of science such as Hemolysis, Blockade, Diagnostic dilemma, Atypical hemolytic uremic syndrome and Immunology.
Her Aflibercept research is multidisciplinary, incorporating perspectives in Angiogenesis, Kidney, Nephrotoxicity, Ranibizumab and Pharmacology.
Her Diabetic retinopathy research is multidisciplinary, relying on both Renal pathology, Urology, Nephrotic syndrome, Acute kidney injury and Proteinuria.
Her research brings together the fields of Kidney disease and Proteinuria.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
